Cargando…
SUN-165 The Largest Single-Center Experience of GLP-1 Receptor Agonists as a Safe and Effective Agent for the Management of Diabetes in Solid Organ Transplant (SOT) Recipients
Background Post-transplant diabetes mellitus is a well-recognized complication of SOT. There is a limited published data regarding the approach to management. We aim to test the efficacy and safety of a GLP-1 analog, dulaglutide, an incretin-based therapy in this population. Methods We performed a r...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Endocrine Society
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553350/ http://dx.doi.org/10.1210/js.2019-SUN-165 |